Latest Articles

Publication Date
Genetic risk may rival obesity as a key driver of endometrial cancer - Medical Xpress

Genetic risk may rival obesity as a key driver of endometrial cancer Medical Xpress

Published: Feb. 12, 2026, 8:16 p.m.
How Should Inoperable Endometrial Cancer be Treated? - CancerNetwork

How Should Inoperable Endometrial Cancer be Treated? CancerNetwork

Published: Feb. 12, 2026, 4:05 p.m.
Endometrial immune cell profile at the time of frozen embryo transfer as prognostic indicator of live birth - Frontiers

Endometrial immune cell profile at the time of frozen embryo transfer as prognostic indicator of live birth Frontiers

Published: Feb. 12, 2026, 1:22 p.m.
I have endometriosis and it inflamed my psoriasis – but it was a fight to be heard - MSN

I have endometriosis and it inflamed my psoriasis – but it was a fight to be heard MSN

Published: Feb. 12, 2026, 7:46 a.m.
Halsey explains ‘bittersweet’ endometriosis diagnosis - The News International

Halsey explains ‘bittersweet’ endometriosis diagnosis The News International

Published: Feb. 12, 2026, 5:27 a.m.
Halsey explains ‘bittersweet’ endometriosis diagnosis - thenews.com.pk

Halsey explains ‘bittersweet’ endometriosis diagnosis thenews.com.pk

Published: Feb. 12, 2026, 5:27 a.m.
Ambulance service pledges to be an Endometriosis Friendly Employer - Emergency Services Times

Ambulance service pledges to be an Endometriosis Friendly Employer Emergency Services Times

Published: Feb. 12, 2026, 12:01 a.m.
Exploring the therapeutic potential of disulfiram in endometriosis: mechanisms targeting inflammation, oxidative stress, pyroptosis, and angiogenesis.

Endometriosis (EMS) is a prevalent, inflammatory gynecological disorder with limited effective treatments and high recurrence rates. Given the central roles of inflammation, oxidative stress, pyroptosis, and angiogenesis in its pathogenesis, …

Published: Feb. 12, 2026, midnight
Atypical gelation of Elagolix sodium in aqueous media: Mechanistic insights and Inhibition via coamorphization.

Elagolix sodium (ELS), a non-peptide oral gonadotropin-releasing hormone receptor (GnRH) antagonist approved for the treatment of endometriosis-associated pain, displays atypical gelation in aqueous environments along with challenging physical properties such …

Published: Feb. 12, 2026, midnight
Ten-Step Approach to Ileocolonic Anastomosis with Natural Orifice Specimen Extraction (NOSE) for Deep Endometriosis.

Published: Feb. 12, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!